DGAP-Adhoc: Alphaform AG: Alphaform realignment on track

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 18, 2014 at 8:45 AM

Alphaform AG / Key word(s): Half Year Results/Half Year Results 18.07.2014 14:37 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad hoc disclosure Preliminary figures for the first half of 2014: Alphaform realignment on track Revenue increases by 15.4% to around EUR 7.0 million in Q2 compared with around EUR 6.0 million in the same period of previous year Q2 operating result improves by EUR 0.4 million year on year to EUR -0.5 million Forecast for year as a whole confirmed again Feldkirchen, 18 July 2014 - Alphaform AG, a service provider for industrial 3-D printing, is on course to achieve its announced realignment. For the second quarter of 2014, the company reported an increase in revenues of around 15.4% to EUR 7.0 million. Over the first half of the year as a whole, therefore, growth of 14.9% and revenue of EUR 14.5 million (previous year: EUR 12.6 million) were achieved. This development was supported by a stable economy during the reporting period. The profit/loss before taxes (operating result) was improved by EUR 0.4 million in the second quarter of 2014 to EUR -0.5 million, after EUR -0.9 million in the same quarter of the previous year. The negative operating result was primarily due to restructuring costs and expected seasonal factors. In the first half of the year as a whole, the operating result was EUR -0.8 million, and it therefore improved by EUR 0.1 million compared to the same period of the previous year (EUR -0.9 million). In the second quarter of 2014, EBITDA was EUR -0.2 million compared to EUR -0.6 million in the same quarter of the previous year; in the first half of 2014 it was EUR -0.2 million compared to EUR -0.3 million in the first half of 2013. Cash flow from operating activities in the first six months of business year 2014 was EUR -2.4 million, compared with EUR -0.2 million in the reporting period of the previous year. The main reason for this was the need for additional working capital due to the business expansion and the costs for restructuring. More information can be found in the corporate news release on the first half of 2014 published on 8 August 2014 or the report for the first half of 2014 available at www.alphaform.de on the same date. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: About Alphaform Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The company belongs to the European market leaders in the production of complex components means additive manufacturing, which are often grouped together under the term '3D printing'. An important mainstay of the segment 3D Printing and Additive Manufacturing is the production of series close prototypes, particularly for the automotive and capital goods industries. The Medical Division of Alphaform has a leading position throughout Europe in manufacturing and processing orthopaedic implants and instruments. The shares of Alphaform are listed in the Prime Standard Segment of the Frankfurt Stock Exchange (FWB) under the abbreviation ATF. The core competence of Alphaform lies in its extensive application know-how for processes and materials for the additive production of complex prototypes, tools, individual components and small series made of plastic and metal. The company's activity is focused on the orthopaedic and medical technology, automotive, aviation and aerospace industries. The subsidiaries of Alphaform are located in Germany, Finland, Sweden and the UK. Contact: Dr. Hanns-Dieter Aberle CEO ALPHAFORM AG KapellenstraÃe 10 85622 Feldkirchen Tel.: +49 89 905002 35 Fax: +49 89 905002 1035 e-mail: hdaberle@alphaform.de Internet: www.alphaform.de 18.07.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Alphaform AG KapellenstraÃe 10 85622 Feldkirchen Germany Phone: +49 (0)89 905002 - 0 Fax: +49 (0)89 905002 - 90 E-mail: ir@alphaform.de Internet: www.alphaform.de ISIN: DE0005487953 WKN: 548795 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, MÃ¼nchen, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

IDEAYA's IDE101: A New Front in Cancer Battle

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Beef 'O' Brady's Expands Into Tuscaloosa Market

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Princess Cruises Launches New Era at Celebration Key

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...